BID and pancreatic neoplasm: Such regulatory axis was verified in both in vitro and in vivo settings, and our data demonstrated that LINC00472 silencing had fundamentally suppressed BID expression through miR‐23a‐3p‐mediated inhibition of FOXO3 to promote proliferation and inhibit the apoptosis of pancreatic cancer cells.